Eslicarbazepine

Eslicarbazepine Makes First Appearance in China at Sichuan University’s West China Lecheng Hospital

Eslicarbazepine, a voltage-gated sodium channel blocker, co-developed by Bial-Portela, Eisai, and Sumitomo Pharma, was first...